Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2012
11/14/2012EP2521553A2 Methods and compositions of targeted drug development
11/14/2012EP2521551A2 Methods and compositions of targeted drug development
11/14/2012EP2521549A1 Therapeutic compounds and related methods of use
11/14/2012CN102781940A Substituted imidazopyridinyl-aminopyridine compounds
11/14/2012CN102781933A Substituted benzoazepines as toll-like receptor modulators
11/14/2012CN102781931A 5-alkynyl pyrimidines and their use as kinase inhibitors
11/14/2012CN102781930A Novel anti-platelet agent
11/14/2012CN102781929A Nicotine haptens, immunoconjugates and their uses
11/14/2012CN102781923A 5-alkynyl-pyrimidines
11/14/2012CN102781919A Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
11/14/2012CN102781918A Substituted pyridyl compound and organic electroluminescent element
11/14/2012CN102781916A Compounds as bradykinin B1 antagonists
11/14/2012CN102781915A Inhibitors of diacylglycerol acyl transferase
11/14/2012CN102781914A Indole derivative
11/14/2012CN102775390A Pyrazolidine alcohol compound and preparation method thereof
11/14/2012CN102775389A Preparation method of N-substituted-4-(7-chloro-quinoline -4-amino)-benzamide derivatives, and application thereof
11/14/2012CN102775388A Method and apparatus for producing oxidized compound
11/14/2012CN102775387A Method for refining fasudil hydrochloride
11/14/2012CN102775386A Preparation method and application of open-ring nitromethylene derivative
11/14/2012CN102775385A N-substituted phenyl-N'-substituted heterocyclic urea compounds and application of same as anti-cancer drugs
11/14/2012CN102775384A Broussone-tine I and J analogue and preparation method and applications thereof
11/14/2012CN102775383A Organic compound for controlling plant viruses and application thereof
11/14/2012CN102775382A Preparation method of pyrazole alkanol compound
11/14/2012CN102775360A Triazole ring-containing asymmetric disulfide ether compounds, synthesis method and usage thereof
11/14/2012CN102775356A 4-aminoquinazoline derivative and application thereof
11/14/2012CN102351845B Method for selectively preparing S-(-)-omeprazole by using high enantiomer
11/14/2012CN102015645B Piperidine and pyrrolidine compounds
11/14/2012CN101611012B Cycloalkylamine substituted isoquinoline derivatives
11/14/2012CN101578273B Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
11/14/2012CN101541747B Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/14/2012CN101535268B Tyrosine kinase inhibitors
11/14/2012CN101450938B 7-(4-oximido-3-amido-3-alkyl-1-piperidine)quinoline carboxylic acid derivates and preparation method thereof
11/14/2012CN101341138B Cyclic anilino-pyridinotriazines as GSK-3 inhibitors
11/14/2012CN101243066B Delta and epsilon crystal forms of imatinib mesylate
11/13/2012US8309721 HSP90 inhibitory carbazole derivatives, compositions containing same and use thereof
11/13/2012US8309596 Kallikrein 7 modulators
11/13/2012US8309581 Benzimidazole derivatives
11/13/2012US8309580 Heterocyclic compound
11/13/2012US8309567 Spiroindoline derivatives having insecticidal properties
11/13/2012US8309566 Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
11/13/2012US8309561 Phenylalanine derivatives
11/13/2012US8309557 Pyrimidin-4-ylpropanedinitrile derivatives, processes for their preparation and their use as herbicides and plant growth regulators
11/13/2012US8309556 Insecticides, neurodegenerative diseases; Alzheimer's disease
11/13/2012US8309548 Benzene, pyridine, and pyridazine derivatives
11/13/2012US8309543 Compositions useful as inhibitors of voltage-gated sodium channels
11/13/2012CA2651353C Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form .alpha.
11/13/2012CA2563805C Diastereoselective addition of lithiated n-methylimidazole on sulfinimines
11/13/2012CA2511925C Heterocyclic inhibitors of phosphatases, compositions and uses thereof
11/13/2012CA2454306C Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use
11/10/2012CA2830838A1 Process for the preparation of an hiv integrase inhibitor
11/08/2012WO2012151561A1 Compounds for inhibiting cell proliferation in egfr-driven cancers
11/08/2012WO2012151512A2 Bromodomain inhibitors and uses thereof
11/08/2012WO2012151137A1 Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
11/08/2012WO2012150952A1 Novel compounds and compositions for the inhibition of nampt
11/08/2012WO2012150829A2 Noble triazolopyridine derivative or pharmaceutically acceptable salts thereof, production method thereof, and pharmaceutical composition including same
11/08/2012WO2012150784A2 Novel indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient
11/08/2012WO2012150234A1 Dihydroquinoline derivatives as bromodomain inhibitors
11/08/2012WO2012125832A3 Antimicrobial agents
11/08/2012WO2012122865A3 Pharmaceutically acceptable salt of (e)-n-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2r)-1-methylpyrrolidin-2-yl]prop-2-enamide, preparation method therefor, and medical use thereof
11/08/2012WO2012118812A3 Substituted 6,5-fused bicyclic heteroaryl compounds
11/08/2012WO2012117021A3 Microbiocidal oxime ethers
11/08/2012WO2012092411A3 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
11/08/2012WO2012083112A3 C- 17 -heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
11/08/2012US20120283442 Novel chemical compounds capable of complexing at least one metal element and a coordination complex based on these compounds
11/08/2012US20120283292 Fatty acid lenalidomide and their uses
11/08/2012US20120283265 Compounds useful for treating aids
11/08/2012US20120283261 Substituted n-phenylpyrimidin-2-amine analogs as inhibitors of the axl kinase
11/08/2012US20120283260 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
11/08/2012US20120283259 Novel inhibitors
11/08/2012US20120283256 New heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs
11/08/2012US20120283243 Spiroindoline Modulators of Muscarinic Receptors
11/08/2012US20120283242 Di - substituted pyridine derivatives as anticancers
11/08/2012US20120283229 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
11/08/2012US20120283137 Mass labels
11/08/2012US20120282223 Amorphous (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-Acetic Acid
11/08/2012US20120282218 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
11/08/2012US20120280613 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode
11/08/2012US20120280221 Material for organic photoelectric device including electron transporting unit and hole transporting unit, and organic photoelectric device including the same
11/08/2012CA2834746A1 Novel compounds and compositions for the inhibition of nampt
11/08/2012CA2834043A1 Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
11/08/2012CA2832504A1 Compounds for inhibiting cell proliferation in egfr-driven cancers
11/07/2012EP2520571A1 2-azatriphenylene materials for organic light emitting diodes
11/07/2012EP2520570A1 Aminopyridine compound
11/07/2012EP2520566A1 New Pharmaceutical Compounds
11/07/2012EP2519664A1 Ligand-directed covalent modification of protein
11/07/2012EP2519522A2 Substituted imidazopyridinyl-aminopyridine compounds
11/07/2012EP2519519A2 Substituted naphthalenyl-pyrimidine compounds
11/07/2012EP2519516A2 Fungicidal hydroximoyl-tetrazole derivatives
11/07/2012EP2519515A1 Pyrazine derivatives and their use in the treatment of neurological disorders
11/07/2012EP2519514A2 Alpha4beta2 neuronal nicotinic acetylcholine receptor ligands
11/07/2012EP2519511A1 Novel piperine derivatives as gaba - a receptors modulators
11/07/2012EP2519505A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
11/07/2012EP2519504A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives.
11/07/2012EP2519503A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
11/07/2012EP2519500A1 Inhibitors of diacylglycerol acyl transferase
11/07/2012EP2519499A1 Pesticidal arylpyrrolidines
11/07/2012CN1832929B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/07/2012CN102770981A Organic electroluminescent element
11/07/2012CN102770426A Compounds and compositions as protein kinase inhibitors
11/07/2012CN102770425A Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors
1 ... 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 ... 1080